Global Vascular Grafts Market By Type (Endovascular Aneurysm Repair (EVAR) Grafts, Peripheral Vascular Grafts, Hemodialysis Access Grafts, Coronary Artery Bypass Grafts (CABG)), By Application (Aneury...

The was valued at USD 2.4 billion in 2023 and is projected to reach USD 4.1 billion by 2030, registering a CAGR of 8.1% during the forecast period of 2023-2030. Rising cases of cardiovascular diseases, advancements in surgical methods and demand for minimally invasive procedures are key factors driving this market. Vascular grafts are essential tools for the replacement, correction of and bypass damaged blood vessels, which can help patients with many vascular diseases to maintain their health.

Drivers:

Prevalence of Cardiovascular Diseases, Advancements in Surgical Techniques, and Demand for Minimally Invasive Procedures

• Cardiovascular Diseases: The growing prevalence of cardiovascular diseases such as atherosclerosis, aneurysms and peripheral artery disease drives the vascular grafts market. Growing requirements for surgical treatments associated with these diseases is boosting demand in the market, thereby propelling the need for vascular grafts.

• Surgical Advancements: The continued improvement in techniques has progressed the success and recovery rates of vascular surgeries such as endovascular aneurysm repair (EVAR) along with minimally invasive means. Increasing sales in the marketplace is beneficial in enhancing patient outcomes.

• Minimally Invasive Procedures: Vascular grafts are increasingly being adopted owing to the growing preference of patients and providers towards minimally invasive procedures. These operations provide advantages like fewer hospital days, lower complication chances and quicker go back to normal activities.

Restraints:

High Costs and Complications Associated with Grafts

• High Costs: The high costs associated with vascular grafts and related surgical procedures can be a significant barrier, even in the lower-income zones. The cost of graft materials, surgical instruments, and postoperative care may affect market expansion.

• Complications: Infection, scarring (graft rejection), and clotting can compromise vascular graft placement. The safety and efficacy of these medical devices is paramount to attract patients as well as physicians.

Opportunity:

Emerging Markets, Technological Innovations, and Increasing Geriatric Population

• Emerging Markets: An expanded marketplace that is largely untapped in particularly new emerging markets. The increasing healthcare expenditure, improving healthcare infrastructure in developing nations and awareness about vascular diseases are expected to drive demand for vascular grafts respectively.

• Technological Innovations: There has been rapid progress in graft materials, like bioengineered along with synthetic grafts, and opening up avenues for a surge. Advances in graft design and fabrication processes are improving the properties of vascular grafts, thus increasing their functionality and lifespan.

• Geriatric Population: The geriatric population, which is more prone to cardiovascular disorders owing to lower heart and vascular elasticity is anticipated to propel the demand for vascular grafts. The demand for successful vascular interventions is set to increase as life expectancies improve.

Market by Product Type Insights:

Endovascular Stent Grafts and Peripheral Vascular Grafts Dominate the Market

• Endovascular Stent Grafts: This segment was developed as the largest revenue contributor in 2023 and will remain the same during the forecast period. Endovascular stent grafts are commonly developed for minimally invasive treatment of aneurysms and other vascular conditions.

• Peripheral Vascular Grafts: Peripheral vascular grafts have also been in high demand, due to the rapidly growing prevalence of peripheral artery disease and vital requirements for effective treatment strategies.

Market by End-use Insights:

Hospitals and Ambulatory Surgical Centers Lead the Market

• Hospitals: In 2023, hospitals were the largest share of the Domestic Healthcare Market Holding over 70% within healthcare segmentation. Vascular surgeries are usually done within hospitals, which have all the supportive infrastructure and professionals to conduct more complex procedures.

• Ambulatory Surgical Centers: Due to their cost-effectiveness, shorter patient stays and advanced specialized care ambulatory surgical centers have developed exceptionally for vascular procedures.

Market by Regional Insights:

North America Holds the Largest Market Share

• North America: In 2023, North America dominated the market share due to a well-established healthcare infrastructure followed by the high prevalence of cardiovascular diseases and considerable investments in medical technology. Major players present in the market and the implementation of favourable reimbursement policies are also fueling the market growth.

Competitive Scenario:

Major players in the Global Vascular Grafts Market include Medtronic plc, B. Braun Melsungen AG, W. L. Gore & Associates, Inc., Terumo Corporation, Getinge AB, Cook Medical, LeMaitre Vascular, Inc., Endologix, Inc., CryoLife, Inc., and Boston Scientific Corporation. These companies are driving innovation and market growth through continuous product development, strategic partnerships, and mergers and acquisitions.

Scope of Work – Global Vascular Grafts Market Report Metric Details

Key Market Developments:

• May 2021-Endologix launched the Alto abdominal stent graft system in Argentina and Canada following clearance by the Argentinian regulatory body and Health Canada. This device was the newest in polymer-based therapies for patients with abdominal aortic aneurysms

• August 2022-W. L. Gore & Associates, Inc., purchased InnAVasc Medical, an innovator in grafts that address bleeding and vascular damage to the back of dialysis access sites

• September 2023-MicroPort Scientific Corporation announced that it has received registration approval from the Thailand Food and Drug Administration (TFDA) for three products: Castor Branched Aortic Stent-Graft, Hercules Thoracic Stent Graft System and Minos Abdominal Aortic stent-graft.

Market Segmentation:

• Based on Product Type:

• Endovascular Stent Grafts

• Peripheral Vascular Grafts

• Hemodialysis Access Grafts

• Coronary Artery Bypass Grafts

• Based on End Use:

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

• Based on Region:

• North America (U.S., Canada)

• Europe (Germany, France, UK, Rest of Europe)

• Asia-Pacific (China, Japan, India, Rest of Asia-Pacific)

• Latin America (Brazil, Mexico, Rest of Latin America)

• Middle East & Africa (South Africa, UAE, Rest of MEA)

Frequently Asked Questions:

Q. What is the current market size of the Global Vascular Grafts Market?
A. The global vascular grafts market size was estimated at USD 2.4 billion in 2023 and is expected to reach USD 4.1 billion by 2030, registering a CAGR of 8.1% during the forecast period of 2023-2030.

Q. What are the major growth drivers of the Global Vascular Grafts Market?

A. The growth of the Global Vascular Grafts Market is mainly driven by the increasing prevalence of cardiovascular diseases, advancements in surgical techniques, and the rising demand for minimally invasive procedures.

Q. Which region holds the largest market share in the Global Vascular Grafts Market?
A. North America accounted for more than 40% of the market share in 2023, driven by advanced healthcare infrastructure and a high prevalence of cardiovascular diseases.

Q. Who are the key market players in the Global Vascular Grafts Market?
A. Key players include Medtronic plc, B. Braun Melsungen AG, W. L. Gore & Associates, Inc., Terumo Corporation, Getinge AB, Cook Medical, LeMaitre Vascular, Inc., Endologix, Inc., CryoLife, Inc., and Boston Scientific Corporation.